Do you want to read an article? Please log in or register.
Donor-derived Philadelphia chromosome positive B-cell lymphoblastic leukemia presenting with renal allograft involvement in the first year post-transplant
Leukemia
Related content
Lymphoma
CD19-Directed CAR T Cells Treatment in a Patient With Refractory DLBCL and CNS Involvement
healthbook TIMS Oncology Hematology
Ring A, Müller A
doi: 10.36000/hbT.OH.2019.01.005
Lymphoma
Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin
healthbook Times Oncology Hematology
Schmidt A
doi: 10.36000/hbT.OH.2020.06.025
Lymphoma
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
Lancet Oncol.
Chiappella A, Martelli M, Angelucci E, Brusamolino E, Evangelista A, Carella AM, Stelitano C, Rossi G, Balzarotti M, Merli F, Gaidano G, Pavone V, Rigacci L, Zaja F, D'Arco A, Cascavilla N, Russo E, Castellino A, Gotti M, Congiu AG, Cabras MG, Tucci A, Agostinelli C, Ciccone G, Pileri SA, Vitolo U
doi: 10.1016/S1470-
Leukemia
Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia
Pediatr Blood Cancer.
Mayfield JR, Czuchlewski DR, Gale JM, Matlawska-Wasowska K, Vasef MA, Nickl C, Pickett G, Ness SA, Winter SS
doi: 10.1002/pbc.26328.
Leukemia
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
Br J Cancer.
Forero-Castro M, Robledo C, Benito R, Bodega-Mayor I, Rapado I, Hernández-Sánchez M, Abáigar M, Maria Hernández-Sánchez J, Quijada-Álamo M, María Sánchez-Pina J, Sala-Valdés M, Araujo-Silva F, Kohlmann A, Luis Fuster J, Arefi M, de Las Heras N, Riesco S, Rodríguez JN, Hermosín L, Ribera J, Camos Guijosa M, Ramírez M, de Heredia Rubio CD, Barragán E, Martínez J, Ribera JM, Fernández-Ruiz E, Hernández-Rivas JM
doi: 10.1038/bjc.2017.152.
Lymphoma
Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy
★ 1
Recommended by
Prof. Dr Christoph Renner, Faculty Member
Blood Rev.
Bachanova V, Perales MA, Abramson JS
doi: 10.1016/j.blre.2019.100640.
Multiple Myeloma (MM)
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis
J Clin Oncol.
McCarthy PL, Holstein SA, Petrucci MT, Richardson PG, Hulin C, Tosi P, Bringhen S, Musto P, Anderson KC, Caillot D, Gay F, Moreau P, Marit G, Jung SH, Yu Z, Winograd B, Knight RD, Palumbo A, Attal M
doi: 10.1200/
Lymphoma
Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma
N Engl J Med.
Abramson JS, McGree B, Noyes S, Plummer, S, Wong C, Chen Y, Palmer E, Albertson T, Ferry JA, Arrillaga-Romany IC
doi: 10.1056/NEJMc1704610.
Lymphoma
Cerebellar large B-cell lymphoma: a case report
doi: 10.1186/s13256-018-1880-z.